Revenue from operations rose to Rs 1,010 crore for the September quarter compared with Rs 957 crore in the year-ago period, ...

Begin your TipRanks Premium journey today. GlaxoSmithKline (GSK) Company Description: In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company ...

Bernstein analyst Justin Smith maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...

British pharmaceutical company GSK reported on Wednesday that its third-quarter profit before tax dropped to £64 million ($83 ...

GlaxoSmithKline Pharmaceuticals on Tuesday reported a 16 per cent year-on-year increase in its consolidated net profit to Rs ...

No Data For Bulk Deal. *Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline ...

Meanwhile, the value of five pharmaceutical companies fell in 2017 as Merck & Co, Celgene, GlaxoSmithKline (GSK), Allergan and Shire all saw their market capitalisation decline. But there was ...

India's GlaxoSmithKline Pharmaceuticals reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and vaccines.

DelveInsight's 'Severe Asthma Pipeline Insight 2024' report provides comprehensive global coverage of pipeline severe asthma ...

GlaxoSmithKline Pharmaceuticals reports a 16% jump in Q2 net profit to Rs 252 crore, driven by strong sales across segments.

GlaxoSmithKline Pharmaceuticals said in a regulatory filing. The company said its board declared a special interim dividend of Rs 12 per equity share of face value of Rs 10 each. "As we mark our ...